Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Apr;73(7):925–930. doi: 10.1038/bjc.1996.165

Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.

N van der Veen 1, H S de Bruijn 1, R J Berg 1, W M Star 1
PMCID: PMC2074259  PMID: 8611408

Abstract

In this study the kinetics and localisation of protoporphyrin IX (PpIX) fluorescence in skin and skin tumours were examined after topically (20% for 4h) or systemically (200 mg/kg,i.p.) administered 5-aminolaevulinic acid (ALA). As a model we used hairless mice with skin lesions (actinic keratoses and squamous cell carcinoma), which were induced by daily UVB irradiation. The epidermis of the skin surrounding the tumours (T) was altered (AS); owing to the UVB irradiation, the epidermis was thicker and less elastic. Therefore, non-UVB-irradiated mice were used to assess fluorescence of normal skin (NS). Light from a halogen lamp was used to excite at 500 +/- 20 nm and fluorescence was detected through a filter that passes light of 670 +/- 50 nm. Maximal fluorescence following i.p. ALA was observed 2 h post injection (p.i.) and was three times less than after topically applied ALA. Furthermore, after i.p. ALA a lower T selectively (T/NS) could be obtained than after topically applied ALA. Maximal fluorescence following topically applied ALA was achieved 6 h after the end of the 4 h application time. At that interval fluorescence of T was twice as high as directly after the application period. Furthermore, T selectivity (T/NS) after topical ALA at the interval of maximal fluorescence was higher than at the interval directly after application. With fluorescence cryomicroscopy localisation of fluorescence in the skin at the interval of maximal fluorescence was determined after both administration routes. For both cases fluorescence was mainly located in T, epidermis and hair follicles. Fluorescence in subcutis could only be observed at 2 h post i.p. ALA and a 6 h post topical ALA. No fluorescence could be observed in muscle. We conclude that, in this model and with these ALA doses, a higher fluorescence intensity and selectivity (T/NS) was achieved after topically applied ALA than after systemically administered ALA. These results make topically applied ALA more favourable for ALA-PDT of superficial skin tumours in this model. In general these results imply that by optimising the time after ALA application the efficacy and selectivity of topical ALA-PDT for skin tumours may be improved.

Full text

PDF
925

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedwell J., MacRobert A. J., Phillips D., Bown S. G. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer. 1992 Jun;65(6):818–824. doi: 10.1038/bjc.1992.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cairnduff F., Stringer M. R., Hudson E. J., Ash D. V., Brown S. B. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 1994 Mar;69(3):605–608. doi: 10.1038/bjc.1994.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Gruijl F. R., Van Der Meer J. B., Van Der Leun J. C. Dose-time dependency of tumor formation by chronic UV exposure. Photochem Photobiol. 1983 Jan;37(1):53–62. doi: 10.1111/j.1751-1097.1983.tb04433.x. [DOI] [PubMed] [Google Scholar]
  4. Divaris D. X., Kennedy J. C., Pottier R. H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990 Apr;136(4):891–897. [PMC free article] [PubMed] [Google Scholar]
  5. Fears T. R., Scotto J., Schneiderman M. A. Skin cancer, melanoma, and sunlight. Am J Public Health. 1976 May;66(5):461–464. doi: 10.2105/ajph.66.5.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fukuda H., Paredes S., Batlle A. M. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Drug Des Deliv. 1989 Dec;5(2):133–139. [PubMed] [Google Scholar]
  7. Goff B. A., Bachor R., Kollias N., Hasan T. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J Photochem Photobiol B. 1992 Aug 31;15(3):239–251. doi: 10.1016/1011-1344(92)85128-h. [DOI] [PubMed] [Google Scholar]
  8. Grant W. E., Hopper C., MacRobert A. J., Speight P. M., Bown S. G. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet. 1993 Jul 17;342(8864):147–148. doi: 10.1016/0140-6736(93)91347-o. [DOI] [PubMed] [Google Scholar]
  9. Iinuma S., Bachor R., Flotte T., Hasan T. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol. 1995 Mar;153(3 Pt 1):802–806. [PubMed] [Google Scholar]
  10. Kennedy J. C., Pottier R. H., Pross D. C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990 Jun;6(1-2):143–148. doi: 10.1016/1011-1344(90)85083-9. [DOI] [PubMed] [Google Scholar]
  11. Kriegmair M., Baumgartner R., Knuechel R., Steinbach P., Ehsan A., Lumper W., Hofstädter F., Hofstetter A. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 1994 Dec;44(6):836–841. doi: 10.1016/s0090-4295(94)80167-3. [DOI] [PubMed] [Google Scholar]
  12. Loh C. S., Vernon D., MacRobert A. J., Bedwell J., Bown S. G., Brown S. B. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B. 1993 Sep;20(1):47–54. doi: 10.1016/1011-1344(93)80130-2. [DOI] [PubMed] [Google Scholar]
  13. Malik Z., Kostenich G., Roitman L., Ehrenberg B., Orenstein A. Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol B. 1995 Jun;28(3):213–218. doi: 10.1016/1011-1344(95)07117-k. [DOI] [PubMed] [Google Scholar]
  14. Orth K., König K., Genze F., Rück A. Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins. J Cancer Res Clin Oncol. 1994;120(11):657–661. doi: 10.1007/BF01245377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Peng Q., Moan J., Warloe T., Nesland J. M., Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer. 1992 Sep 30;52(3):433–443. doi: 10.1002/ijc.2910520318. [DOI] [PubMed] [Google Scholar]
  16. Regula J., MacRobert A. J., Gorchein A., Buonaccorsi G. A., Thorpe S. M., Spencer G. M., Hatfield A. R., Bown S. G. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. Gut. 1995 Jan;36(1):67–75. doi: 10.1136/gut.36.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sterenborg H. J., de Gruijl F. R., van der Leun J. C. UV-induced epidermal hyperplasia in hairless mice. Photodermatol. 1986 Aug;3(4):206–214. [PubMed] [Google Scholar]
  18. Svanberg K., Andersson T., Killander D., Wang I., Stenram U., Andersson-Engels S., Berg R., Johansson J., Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994 Jun;130(6):743–751. doi: 10.1111/j.1365-2133.1994.tb03412.x. [DOI] [PubMed] [Google Scholar]
  19. Szeimies R. M., Sassy T., Landthaler M. Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol. 1994 Jan;59(1):73–76. doi: 10.1111/j.1751-1097.1994.tb05003.x. [DOI] [PubMed] [Google Scholar]
  20. Van Hillegersberg R., Van den Berg J. W., Kort W. J., Terpstra O. T., Wilson J. H. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology. 1992 Aug;103(2):647–651. doi: 10.1016/0016-5085(92)90860-2. [DOI] [PubMed] [Google Scholar]
  21. Wolf P., Rieger E., Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol. 1993 Jan;28(1):17–21. doi: 10.1016/0190-9622(93)70002-b. [DOI] [PubMed] [Google Scholar]
  22. van der Veen N., van Leengoed H. L., Star W. M. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer. 1994 Nov;70(5):867–872. doi: 10.1038/bjc.1994.412. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES